In 2017 the American Cancer Society (ACS) reported
there were 252,700 invasive & 63,410 non-invasive cases of Breast Cancer in Women
with 73,164 deaths and
2,470 cases of Breast Cancer in men.
During my tenure in Reno, NV, I continued to carry out investigations into the use of FMTVDM in the community setting.
Volunteers who participated in some of that work were kind enough to share their first hand experience; talking not only about FMTVDM - BEST as it relates to them personally, but also how FMTVDM - BEST compared to other breast cancer tests they had undergone.
​
Thank you ladies!
FMTVDM - BEST Imaging
FMTVDM-B.E.S.T. imaging is a diagnostic study performed using a variety of cameras and isotopes conducted while enhancing blood flow to various regions allowing us to "quantify" or measure differences in tissue, including breast tissue.
The first part of the study does not involve the person being imaged. This part of the process requires a specific method for calibrating the cameras to guarantee accurate, consistent and reproducible results-something that has been missed in other approaches to measuring and looking for breast and other cancers.
Once this has been done (again before the person ever arrives for their imaging) you are then able to have this study done, which takes roughly 15-20 minutes.
The results are determined, not by having someone look at a picture of your breast, which is associated with errors (inattention blindness) in finding the problem (sensitivity issue) as well as problems with you being told there is a problem (specificity issues) when there isn't; but, by having measurements made of the regional blood flow and metabolism.
The result is an image, which is "quantified" and places your result on the "Health-Spectrum". The "Health-Spectrum" tells you where you are at from having no problems to having, in this instance, breast cancer only. As such, you and your clinician are able to make decisions about what you wish to do next.
Should you undergo treatment, FMTVDM-B.E.S.T. can actually be repeated following your first treatment (or anytime thereafter) to measure the effect of your treatment. This too will allow you to make a decision about whether you need to change treatment, providing the first truly quantitative patient-oriented/patient-specific/patient-oriented treatment; saving time, money and most importantly lives.
The Consequences of Uncertainty.
Half of all women have dense breasts
making mammography unreliable.
Mammography Didn't Save My Life.
Story of a woman who had FMTVDM - BEST.
Giving her valuable information about the effect of her chemotherapy. "I had harder tests in high school."
FMTVDM (BEST Breast Cancer) Imaging
for the 50% of Women who have Dense Breasts.
The Stress, Uncertainty, Fear and Pain of Not Knowing.
Lessons We Learn Along the Way.